CMA proposes Aspen pay-for-delay settlement

Emily Craig

14 August 2019

CMA proposes Aspen pay-for-delay settlement

Credit: iStock/okskaz

The UK’s competition authority has provisionally accepted a £10.1 million settlement from Aspen over an agreement that prevented the entry of a competing version of the drug fludrocortisone.